User:Mr. Ibrahem/Ravidasvir

Ravidasvir is a medication used to treat hepatitis C. It is typically used together with sofosbuvir with a 97% cure rate. It can be used in people infected with both hepatitis C and HIV/AIDS. It is taken by mouth.

Side effects are generally minor. In people with diabetes, low blood sugar may occur. In those who also have hepatitis B reactivation may occur. It is a NS5A inhibitor.

Ravidasvir was approved for medical use in Malaysia and Egypt in 2021. It is on the World Health Organization's List of Essential Medicines. A 12 week course of treatment is expected to cost about 300 to 500 USD.